Frédérique Spyratos

Author

Frédérique Spyratos

Also Known As

F Spyratos, F. Spyratos, FRÉDÉRIQUE SPYRATOS, Frederique Spyratos, Frédérique Spyratos, Fréderique Spyratos, Frédérique Spyratos

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Hôpital René Huguenin Inserm Institut Curie Institut Gustave Roussy Université Paris Cité

About

Frédérique Spyratos is an author at Hôpital René Huguenin specializing in breast cancer, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1K
2	Cell Biology	4	4	217
3	Biostatistics	2	2	66
4	Endocrinology	2	2	138
5	Health Sciences	1	1	63

Frédérique Spyratos

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy, JNCI Journal of the National Cancer Institute	2002	600
CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER Frédérique Spyratos, K. Hacène, Jacques Rouëssé, The Lancet Cathepsin DBreast OncologyMedicinePathologyBreast Cancer	1989	319
Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors. Martine Perrot‐Applanat, Marie‐Thérèse Groyer‐Picard, Frédéric Lorenzo, PubMed Human Breast TumorsBreast OncologyImmunocytochemical TechniqueImmunologyGynecology	1987	118
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group Sabine Maier, Inko Nimmrich, Thomas Koenig, European Journal of Cancer Tumor BiologyBreast OncologyCancer RiskMedicinePathobiology Group	2007	113
PIK3R1 underexpression is an independent prognostic marker in breast cancer Magdalena Čížková, Sophie Vacher, Didier Meseure, BMC Cancer	2013	108
DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy Oliver Hartmann, Frédérique Spyratos, Nadia Harbeck, Clinical Cancer Research	2008	105
Validation of tumor‐associated macrophage ferritin light chain as a prognostic biomarker in node‐negative breast cancer tumors: A multicentric 2004 national PHRC study Pascal Jézéquel, L. Campion, Frédérique Spyratos, International Journal of Cancer Multicentric 2004Breast OncologyNational Phrc StudyPathologyPrognostic Biomarker	2011	94
Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy Ivan Bièche, Sophie Vacher, François Lallemand, Molecular Cancer	2011	74
miRNA expression profiling of inflammatory breast cancer identifies a 5‐miRNA signature predictive of breast tumor aggressiveness Florence Lerebours, Géraldine Cizeron-Clairac, A. Susini, International Journal of Cancer	2013	72
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer Sandra E. Ghayad, Julie A. Vendrell, Ivan Bièche, Journal of Molecular Endocrinology	2008	69

Page 1